Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Dec 13 04:00PM ET
3.24
Dollar change
-0.62
Percentage change
-16.06
%
IndexRUT P/E- EPS (ttm)-2.50 Insider Own49.81% Shs Outstand37.43M Perf Week75.14%
Market Cap101.77M Forward P/E- EPS next Y-2.66 Insider Trans-0.04% Shs Float18.78M Perf Month53.55%
Income-73.95M PEG- EPS next Q-0.75 Inst Own24.81% Short Float1.45% Perf Quarter18.25%
Sales55.08M P/S1.85 EPS this Y87.64% Inst Trans-4.50% Short Ratio0.17 Perf Half Y-41.62%
Book/sh6.83 P/B0.47 EPS next Y-7.39% ROA-19.86% Short Interest0.27M Perf Year-
Cash/sh8.74 P/C0.37 EPS next 5Y- ROE-30.34% 52W Range1.61 - 12.74 Perf YTD-68.57%
Dividend Est.- P/FCF- EPS past 5Y- ROI-24.89% 52W High-74.57% Beta-
Dividend TTM- Quick Ratio6.18 Sales past 5Y3569.20% Gross Margin90.66% 52W Low101.24% ATR (14)0.47
Dividend Ex-Date- Current Ratio6.18 EPS Y/Y TTM- Oper. Margin-160.63% RSI (14)61.42 Volatility35.52% 15.37%
Employees236 Debt/Eq0.18 Sales Y/Y TTM- Profit Margin-134.27% Recom1.25 Target Price16.50
Option/ShortNo / Yes LT Debt/Eq0.16 EPS Q/Q3.46% Payout- Rel Volume1.50 Prev Close3.86
Sales Surprise70.35% EPS Surprise34.26% Sales Q/Q-6.87% EarningsNov 13 AMC Avg Volume1.58M Price3.24
SMA2035.54% SMA5049.92% SMA200-34.94% Trades Volume2,367,502 Change-16.06%
Date Action Analyst Rating Change Price Target Change
May-07-24Initiated H.C. Wainwright Buy $10
May-02-24Downgrade JP Morgan Overweight → Neutral $16 → $6
Mar-05-24Initiated Wells Fargo Overweight $25
Mar-05-24Initiated TD Cowen Outperform
Mar-05-24Initiated JP Morgan Overweight $16
Mar-05-24Initiated Jefferies Buy $23
Mar-05-24Initiated Chardan Capital Markets Buy $21
Mar-05-24Initiated BMO Capital Markets Outperform $22
Dec-11-24 06:30PM
Dec-09-24 09:16PM
Dec-08-24 06:05AM
Nov-18-24 12:00PM
Nov-13-24 04:37PM
04:05PM Loading…
04:05PM
Nov-05-24 04:05PM
Oct-29-24 05:45AM
Oct-24-24 08:04AM
Oct-23-24 05:45AM
Oct-14-24 08:58PM
Oct-01-24 03:14PM
Sep-19-24 07:15PM
Sep-03-24 04:05PM
Aug-29-24 07:32PM
06:10PM Loading…
Aug-28-24 06:10PM
Aug-26-24 09:00PM
Aug-14-24 08:11AM
08:05AM
Aug-12-24 06:29PM
Aug-05-24 09:00PM
Jun-03-24 04:30PM
04:17PM
May-29-24 04:00PM
May-14-24 10:54PM
04:05PM
May-04-24 10:49AM
May-02-24 06:04AM
May-01-24 04:00PM
01:53PM
08:00AM Loading…
Apr-08-24 08:00AM
Mar-27-24 09:16AM
Feb-29-24 04:30PM
Feb-13-24 04:35PM
Feb-08-24 10:16PM
Metagenomi, Inc. is a precision genetic medicines company, which engages in the business of developing next generation gene-editing technologies and therapies. Its business activities include developing gene edit-ing toolbox, ther-a-peu-tic focus, and processing discovery platform. The company was founded by Brian C. Thomas on September 16, 2016 and is headquartered in Emeryville, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Wapnick PamelaChief Financial OfficerDec 05 '24Sale1.861,5592,90061,492Dec 06 04:24 PM
Wapnick PamelaChief Financial OfficerSep 05 '24Sale2.886,26518,04363,051Sep 06 05:14 PM
Novo Holdings A/S10% OwnerFeb 13 '24Buy15.00800,00012,000,0001,739,175Feb 15 08:38 PM
Novo Holdings A/S10% OwnerFeb 09 '24Buy10.25100,0001,025,000100,000Feb 15 08:38 PM